PCN198 - AN ECONOMIC SYSTEMATIC LITERATURE REVIEW (SLR) FOR ANAPLASTIC LYMPHOMA KINASE-POSITIVE (ALK+) NON-SMALL-CELL LUNG CANCER (NSCLC)

Value in Health ◽

10.1016/j.jval.2018.09.280 ◽

2018 ◽

Vol 21 ◽

pp. S47

Author(s):

R.E. Robson ◽

H. Cranmer ◽

J. Huang ◽

R. Selby ◽

H.M. Lin ◽

...

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

PCN155 AN ECONOMIC SYSTEMATIC LITERATURE REVIEW FOR UNTREATED ANAPLASTIC LYMPHOMA KINASE-POSITIVE (ALK+) NON-SMALL-CELL LUNG CANCER (NSCLC)

Value in Health ◽

10.1016/j.jval.2019.09.351 ◽

2019 ◽

Vol 22 ◽

pp. S465

Author(s):

R. Robson ◽

A. Prowse ◽

A. Strickson ◽

C. Cooper

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Abstract 1642: Alectinib in treatment-naïve anaplastic lymphoma kinase-positive (ALK+) metastatic non-small-cell lung cancer (mNSCLC): Systematic literature review (SLR) and network meta-analysis (NMA)

10.1158/1538-7445.am2018-1642 ◽

2018 ◽

Author(s):

Anna Steenrod ◽

Michelle Orme ◽

Katherine S. MacGilchrist ◽

Rachel Rosenthal ◽

Juliane Schaefer ◽

...

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Meta Analysis ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Treatment Naïve

Download Full-text

Systematic Literature Review (SLR) Of Sequencing Of Anaplastic Lymphoma Kinase (ALK) Inhibitors In ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

Value in Health ◽

10.1016/j.jval.2018.04.291 ◽

2018 ◽

Vol 21 ◽

pp. S49-S50 ◽

Author(s):

SM Barrows ◽

K Wright ◽

C Copley-Merriman ◽

JA Kaye ◽

MD Chioda ◽

...

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Alk Inhibitors ◽

Anaplastic Lymphoma ◽

Download Full-text

5P Targeted degradation of anaplastic lymphoma kinase by target degraducer in non-small cell lung cancer

Annals of Oncology ◽

10.1016/s0923-7534(21)00167-8 ◽

2016 ◽

Vol 27 ◽

pp. ix2

Author(s):

J.Y. Hwang ◽

C.-H. Park ◽

D.H. Lee ◽

C.H. Kang ◽

C.O. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Visual Effects in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Crizotinib

Annals of Oncology ◽

10.1016/s0923-7534(20)32041-x ◽

2012 ◽

Vol 23 ◽

pp. xi44

Author(s):

P.-C. Yang ◽

R. Salgia ◽

B. Solomon ◽

A.T. Shaw ◽

D.R. Camidge ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Visual Effects ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

Download Full-text

Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer

Cancer Management and Research ◽

10.2147/cmar.s223441 ◽

2019 ◽

Vol Volume 11 ◽

pp. 9195-9202 ◽

Author(s):

Maobai Liu ◽

Longfeng Zhang ◽

Qishu Huang ◽

Na Li ◽

Bin Zheng ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Cost Effectiveness Analysis ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Effectiveness Analysis

Download Full-text

Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer

Cancer Science ◽

10.1111/j.1349-7006.2011.01970.x ◽

2011 ◽

Vol 102 (8) ◽

pp. 1602-1604 ◽

Author(s):

Takashi Kijima ◽

Kengo Takeuchi ◽

Satoshi Tetsumoto ◽

Kazuki Shimada ◽

Ryo Takahashi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

New England Journal of Medicine ◽

10.1056/nejmx110006 ◽

2011 ◽

Vol 364 (6) ◽

pp. 588-588

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Kinase Inhibition ◽

Anaplastic Lymphoma

Download Full-text

Re‐Evaluating Progression in an Era of Progress: A Review of First‐ and Second‐Line Treatment Options in Anaplastic Lymphoma Kinase‐Positive Non‐Small Cell Lung Cancer

The Oncologist ◽

10.1634/theoncologist.2015-0396 ◽

2016 ◽

Vol 21 (6) ◽

pp. 755-761 ◽

Author(s):

Emily H. Castellanos ◽

Leora Horn

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Treatment Options ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

A Patient With Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer With Development of Leptomeningeal Carcinomatosis While on Targeted Treatment With Crizotinib

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2013.0054 ◽

2013 ◽

Vol 11 (4) ◽

pp. 389-394 ◽

Author(s):

Jonathan W. Riess ◽

Seema Nagpal ◽

Joel W. Neal ◽

Heather A. Wakelee

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Leptomeningeal Carcinomatosis ◽

Targeted Treatment ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text